Macquarie initiated coverage on Surgery Partners with a new price target
$SGRY
Hospital/Nursing Management
Health Care
Macquarie initiated coverage of Surgery Partners with a rating of Outperform and set a new price target of $31.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/18/2025 | $27.00 | Neutral | Analyst |
| 7/28/2025 | $28.00 | Buy | BofA Securities |
| 12/16/2024 | $30.00 | Buy | BofA Securities |
| 10/14/2024 | $38.00 | Buy | UBS |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 6/28/2024 | $31.00 | Outperform | Macquarie |
| 3/6/2024 | $35.00 | Equal Weight | Barclays |
| 11/14/2023 | $39.00 → $35.00 | Market Perform → Outperform | TD Cowen |
BRENTWOOD, Tenn., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 6.6% for the third quarter Same-facility revenues increased 6.3% for the third quarter Surgical cases increased 2.1% for the third quarter Same-facility cases increased 3.4% for the third quarter Net loss attributable to Surgery Partners, Inc. was $22.7 million for the third quarter Adjusted EBITDA increased 6.1% to
BRENTWOOD, Tenn., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2025 results before the market opens on Monday, November 10, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until November 24, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13756022 Interested
BRENTWOOD, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 8.4% for the second quarter Same-facility revenues increased 5.1% for the second quarterSame-facility cases increased 3.4% for the second quarter Net loss attributable to Surgery Partners, Inc. was $2.5 million for the second quarter Adjusted EBITDA increased 9.0% to $129.0 million for the second quarter 2025 Guidance
4 - Surgery Partners, Inc. (0001638833) (Issuer)
4/A - Surgery Partners, Inc. (0001638833) (Issuer)
4 - Surgery Partners, Inc. (0001638833) (Issuer)
Analyst resumed coverage of Surgery Partners with a rating of Neutral and set a new price target of $27.00
BofA Securities resumed coverage of Surgery Partners with a rating of Buy and set a new price target of $28.00
BofA Securities initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $30.00
SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
SCHEDULE 13G - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G - Surgery Partners, Inc. (0001638833) (Subject)
SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
BRENTWOOD, Tenn., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 6.6% for the third quarter Same-facility revenues increased 6.3% for the third quarter Surgical cases increased 2.1% for the third quarter Same-facility cases increased 3.4% for the third quarter Net loss attributable to Surgery Partners, Inc. was $22.7 million for the third quarter Adjusted EBITDA increased 6.1% to
BRENTWOOD, Tenn., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2025 results before the market opens on Monday, November 10, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until November 24, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13756022 Interested
BRENTWOOD, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 8.4% for the second quarter Same-facility revenues increased 5.1% for the second quarterSame-facility cases increased 3.4% for the second quarter Net loss attributable to Surgery Partners, Inc. was $2.5 million for the second quarter Adjusted EBITDA increased 9.0% to $129.0 million for the second quarter 2025 Guidance
BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members. Dr. Forese joins the Surgery Partners Board with extensive healthcare experience. Her career in healthcare administration spans over 40 years, most recently serving as an executive vice president and chief operating officer for New York-Presbyterian, one of the nation's most comprehensive, integrated academic heal
PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,
PLANTATION, Fla., Aug. 12, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") provided a business update and announced the termination of employment of its Chief Financial Officer, William Larkin and the appointment of David Kretschmer as Interim Chief Financial Officer, effective today. The Company has implemented a transformation program with initiatives focused on its operations, growth, and capital. These initiatives are intended to support the Company's objectives with respect to patient access and experience, customer and partner engagement, financial sustainability, and employee well-being. The Company is receiving support from a globally recognized tr